EP1673382A1 - Adrenergic receptor snp for improved milking characteristics - Google Patents

Adrenergic receptor snp for improved milking characteristics

Info

Publication number
EP1673382A1
EP1673382A1 EP04784592A EP04784592A EP1673382A1 EP 1673382 A1 EP1673382 A1 EP 1673382A1 EP 04784592 A EP04784592 A EP 04784592A EP 04784592 A EP04784592 A EP 04784592A EP 1673382 A1 EP1673382 A1 EP 1673382A1
Authority
EP
European Patent Office
Prior art keywords
dna
milking
allele
beta2
pair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04784592A
Other languages
German (de)
French (fr)
Other versions
EP1673382A4 (en
Inventor
Robert J. Collier
Michael Lohius
Michael Grosz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
University of Arizona
Original Assignee
Monsanto Co
University of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co, University of Arizona filed Critical Monsanto Co
Publication of EP1673382A1 publication Critical patent/EP1673382A1/en
Publication of EP1673382A4 publication Critical patent/EP1673382A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/124Animal traits, i.e. production traits, including athletic performance or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Definitions

  • the present invention relates, in general, to the field of molecular biology, human and bovine genetics, and desirable milking characteristics. In particular this invention provides a method for using genetics to predict the milking characteristics of cows.
  • Various publications or patent are referred to throughout this application to describe the state of the art to which the invention pertains. Each of this publications or patents is incorporated by reference herein. Complete citations of scientific publications are set forth in the text or at the end of the specification.
  • ADRB2 bovine beta2-adrenergic receptor
  • a method for breeding cows for improved milking characteristics including the step of screening the genotype of the parents of the cow for the allele associated with a desired SCS phenotype.
  • the method has the steps of obtaining a DNA sample from a bull to be tested for the desired SCS phenotype; and detecting the presence of an adenine at position 11 in a gene encoding a bovine beta2-adrenoreceptor.
  • the method can be performed by direct sequencing, primer extension, restriction length fragment polymorphism, and allele-specific hybridization.
  • a method of identifies a bull whose daughter cows have a short milking duration
  • This method has the steps of obtaining a sample of DNA from a bull; combining the DNA with a pair of PCR probes comprising SEQ IDs 1 and 2 or SEQ IDS 3 and 4; incubating the DNA under conditions permitting the DNA bounded by the PCR probes to produce DNA amplicons; isolating the DNA amplicons; combining the DNA amplicons with a restriction enzyme specific for CCCGGG for a sufficient time to produce a mixture of DNA fragments from the amplicons comprising CCCGGG; applying the DNA fragment mixture to a gel and permitting migration of the mixture components for a time sufficient for them to separate; and observing the sizes of DNA on the gel, with the largest fragments being correlated with the A genotype and with better SCS phenotype, and the smaller fragments being associated with the C genotype and less desirable SCS phenotype.
  • a milking attribute PCR-RFLP kit contains a pair of primers which flank the 11 th nucleotide position of the bovine beta2-adrenoreceptor gene, and a restriction enzyme specific for the CCCGGG site.
  • the restriction enzyme can be Smal.
  • the primer pairs are selected from pair 1 (SEQ ID Nos 1 and 2) or from pair 2 (SEQ ID Nos 3 and
  • ADR2 bovine beta2-adrenoceptor
  • oligonucleotide primers to be used to amplify and perform locus-specific re-sequencing of genomic DNA spanning regions of the bovine ADRB2 gene. These primers were used to amplify genomic DNA from 24 Holstein and 12 Brown Swiss dairy cows. After comparative genomic sequence was obtained, we analyzed the sequence using polyPhred software (Washington University, St. Louis, MO) and identified, among others, a Single Nucleotide Polymorphism (SNP) sequence at position 11, inclusive of the start ATG (hereafter referred to as "Al 1C"). The published sequence indicates the presence of a cytosine (C) nucleotide.
  • SNP Single Nucleotide Polymorphism
  • This polymorphism was found to be associated with milking characteristics.
  • the A allele at the A11C locus is associated with higher somatic cell score (SMS) and therefore with a faster milking speed.
  • SMS somatic cell score
  • the A allele is effective in both the heterozygous and homozygous conditions to improve the performance of the animal.
  • Polymorphism refers generally to the ability of an organism or gene to occur in two or more different forms. In particular for purposes of the present invention, “polymorphism” refers to two or more different forms of the same gene.
  • SNP Single Nucleotide Polymorphism
  • a “Restriction Enzyme” refers to an endonuclease which bins to double stranded
  • Restriction enzymes are denoted by three-letter abbreviations followed by a strain designation and/or a Roman numeral distinguishing different enzymes from the same species or strain. Recognition sequences are written 5' to 3' for one strand only. Examples of restriction enzymes include Smal, BamHi, Bell, EcoRL Hindlll, and Xbal.
  • allelic refers generally to any of one or more alternative forms of a given gene or DNA segment; both or all alleles of a given gene are concerned with the same trait or characteristic, but the product or function coded for by a particular allele differs qualitatively and/or quantitatively from that coded for by other alleles of that gene.
  • allelic pair i.e., the two alleles of a given gene
  • the polynucleotides of the present invention may be prepared by two general methods: (1) They may be synthesized from appropriate nucleotide triphosphates, or (2) they may be isolated from biological sources. Both methods utilize protocols well known in the art. The availability of nucleotide sequence information enables preparation of an isolated nucleic acid molecule of the invention by oligonucleotide synthesis. Synthetic oligonucleotides may be prepared by the phosphoramidite method employed in the Applied Biosystems 37A DNA Synthesizer or similar devices.
  • Buffer RLT (Qiagen)(with 10 ⁇ l jS-mercaptoethanol added per 1 ml buffer) was added to the leukocytes; for a starting blood volume of 4.0 ml or less, 2.0 ml was added; and for a greater blood volume, 4.0 ml was added.
  • the mixture was homogenized until the sample was homogeneous.
  • An equal volume of 70% alcohol was added to the homogenized lysate and vigorously shaken.
  • RNA sample purified as described above were added 0.1 volume of 10X DNase I Buffer and 1 ⁇ l of DNase I (2 units) to the RNA, which solution was mixed gently and incubated at 37°C for 20-30 min.
  • Ambion DNase Inactivation reagent was resuspended by flicking or vortexing. From that tube, the greater of 0.1 volume or 5 ⁇ l was added to the sample and mixed well. The tube was incubated for 2 min at room temperature. The tube was next centrifuged at 10,000 g for about 1 min to pellet the DNase inactivation reagent.
  • RNA concentration was then used to determine RNA concentration, and 1 ⁇ g
  • RNA using Omniscript (Qiagen) for Real Time PCR analysis The Omniscript 10X Buffer RT, dNTP mix and RNase-free water were first thawed and mixed by vortexing. Qiagen RNase inhibitor was diluted to a final concentration of 10 units/ ⁇ l in lx Buffer RT and mixed by vortexing briefly. Master mix (2.0 ⁇ l of lOx Buffer RT, 2.0 ⁇ l dNTP mix, 2.0 ⁇ l oligo dT primer (10 uM), 0.5 ⁇ l Rnase inhibitor (10 units/ ⁇ l), 1.0 ⁇ l Omniscript reverse transcriptase and double distilled water) was prepared on ice. Master solution was distributed to the various tubes, and template RNA (0.6 to 0.68 ⁇ l/tube) was added and mixed. The resulting solutions were incubated at 37°C for 60 min.
  • Bovine DNAs are available from the Cooperative Dairy DNA Repository
  • CDDR CDDR population
  • MS milking speed
  • Table 2 contains average estimated transmitting abilities (ETA) for
  • results from statistical analyses of the data indicate that genotypes AA, AC and CC are significantly different from the mean SCS (p ⁇ 0.025) and that genotypes AA and AC are significantly higher than the mean SCS (p ⁇ 0.01). Furthermore, animals with the CC genotype have significantly different (i.e., lower) SCS phenotypes than animals with AA and AC genotypes (p ⁇ 0.05).
  • Table 3 shows the distribution of milking speed (MS) classifications according to genotype
  • Table 4 illustrates the average ETA for MS by genotype. Because of the small number of AA animals, there is not a significant association between MS and Al lC genotype at the 5% level. However, the trend in Table 3 clearly shows that the CC genotype has a lower proportion of bulls transmitting fast MS.
  • the assay results correlate with the SCS and enable the choice of animals with improved MS and mastitis resistance.
  • these discoveries can also be used to select animals in an attempt to effect population changes in MS and mastitis resistance. Applying the assay will enable the selection of animals with SCS which will ultimately improve the herd averages for MS and mastitis resistance.
  • This invention also includes a kit containing reagents that can be used to identify allelic composition at the loci described herein.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Disclosed herein is a method for screening for the allele associated with a desired SCS phenotype, which comprises: obtaining a DNA sample from a bull to be tested for the desired SCS phenotype; and detecting the presence of an adenine at position 11 in a gene encoding a bovine beta2-adrenoreceptor. Also disclosed is a milking attribute PCR-RFLP kit containing a pair of primers which flank the 11th nucleotide position of the bovine beta2-adrenoreceptor gene, and a restriction enzyme specific for the CCCGGG site, which can be SmaI.

Description

ADRENERGIC RECEPTOR S P FOR IMPROVED MILKING CHARACTERISTICS
CROSS-REFERENCE TO RELATED APPLICATIONS [0001] Not applicable.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT [0002] Not applicable.
BACKGROUND OF THE INVENTION [0003] The present invention relates, in general, to the field of molecular biology, human and bovine genetics, and desirable milking characteristics. In particular this invention provides a method for using genetics to predict the milking characteristics of cows. [0004] Various publications or patent are referred to throughout this application to describe the state of the art to which the invention pertains. Each of this publications or patents is incorporated by reference herein. Complete citations of scientific publications are set forth in the text or at the end of the specification.
[0005] Domestic animals are bred for improvement to the useful attributes of the animals. For cows, one very useful attribute is their milking characteristics, both volume of milk and rate of milking. Many dairy cows are artificially inseminated using semen from sires purchased from companies engaged in selling quality improvement genetics for milking cows. However, while the overall statistical average of the milking characteristics of the daughters of a particular sire can be measured, it is yet not possible to predict with any degree of success the milking characteristics of a particular progeny created by breeding a cow with a particular bull. Better understanding of the genetics of milking traits will be needed in order to more accurately predict the milking characteristics of a particular daughter.
[0006] It is known that some milking characteristics are linked to other traits. A relationships between adrenoceptor concentrations and milkability in primiparous' cows have been elucidated by Roets, et al.("Relationship between milkability and adrenoceptor concentrations in teat tissue in primiparous cows", J Dairy Sci 69(12):2131-3131, 1986). Later, Roets et al. ("Relationship between numbers of alpha2- and beta2-adrenoceptors in teat tissue and blood cells and milkability of primiparous cows", J Dairy Sci 72(12):3304-33-13, 1989) reported on the numbers of alpha2- and beta2-adrenoceptors in teat tissue and blood cells and milkability in primiparous cows. Subsequently, Roets et al.("Relationship between numbers of alpha2- and beta2-adrenoceptors on blood cells of bulls and milkability of their daughters", J Dairy Sci, 62 567-575, 1995) analyzed the numbers of alpha2- and beta2-adrenoceptors on the blood cells of bulls and the milkability of their daughters. In addition, Blum et al.("Catecholamines, oxytocen and milk removal in dairy cows", J Dairy Res, 56(2): 167-177, 1989) reported that treatment with phentolamine (an alpha-adrenergic blocker) and isoproterenol (a beta-adrenoceptor agonist) each facilitated milk removal. Brown et al. ("Relationship of milking rate to somatic cell count", J Dairy Sci, 69(3):850-854, 1986) raised the possibility that milking speed was correlated with both somatic cell score (SCS) and mastitis. Many studies have established correlations between mastitis and SCS (see, for example, MacMillan et al., "Associations between dry cow therapy, clinical mastitis, and somatic cell count score with milk and fat production in ten New Zealand dairy herds", J Dairy Sci, 66(2):259-265, 1983; Reneau, "Effective use of dairy herd improvement somatic cell counts in mastitis control", J Dairy Sci, 69(6): 1708- 1720, 1986; and McClelland, "A comparison of objective and subject measures of milking speed on Canadian Holstein-Friesians", University of Guelph, 1983). Further, a positive correlation between milking speed and SCS was confirmed by Boettcher et al. ("Development of an udder health index for sire selection based on somatic cell score, udder conformation, and milking speed", J Dairy Sci, 81(4):1157-1168, 1998). [0007] The DNA sequence in and around the bovine beta2-adrenergic receptor (ADRB2) gene was in public genome databases (accession numbers Z86037; Einspanier et al., "Expression of the beta2 adrenergic receptor in the cattle", direct submission to Genbank, accession No. Z86037, 1997 and AF331034; Schimpf et al., "Genetic mapping of the ADRB2 gene on cattle chromosome 7", Anim. Genet. 32(6):390, 2001). These sequences included the ADRB2 coding region (1257 bases inclusive from the ATG start to the TAA stop codon), as well as the 223 bases upstream from the ATG start codon and the 550 bases downstream from the TAA stop codon.
[0008] What is needed is a way of determining which bulls will produce cows with improved milkability and a method of improving the results of a breeding program for milkability.
BRIEF SUMMARY OF THE INVENTION [0009] Disclosed herein is a method for breeding cows for improved milking characteristics including the step of screening the genotype of the parents of the cow for the allele associated with a desired SCS phenotype. The method has the steps of obtaining a DNA sample from a bull to be tested for the desired SCS phenotype; and detecting the presence of an adenine at position 11 in a gene encoding a bovine beta2-adrenoreceptor. The method can be performed by direct sequencing, primer extension, restriction length fragment polymorphism, and allele-specific hybridization.
[00010] In another embodiment, a method of identifies a bull whose daughter cows have a short milking duration This method has the steps of obtaining a sample of DNA from a bull; combining the DNA with a pair of PCR probes comprising SEQ IDs 1 and 2 or SEQ IDS 3 and 4; incubating the DNA under conditions permitting the DNA bounded by the PCR probes to produce DNA amplicons; isolating the DNA amplicons; combining the DNA amplicons with a restriction enzyme specific for CCCGGG for a sufficient time to produce a mixture of DNA fragments from the amplicons comprising CCCGGG; applying the DNA fragment mixture to a gel and permitting migration of the mixture components for a time sufficient for them to separate; and observing the sizes of DNA on the gel, with the largest fragments being correlated with the A genotype and with better SCS phenotype, and the smaller fragments being associated with the C genotype and less desirable SCS phenotype.
[00011] In another embodiment a milking attribute PCR-RFLP kit contains a pair of primers which flank the 11th nucleotide position of the bovine beta2-adrenoreceptor gene, and a restriction enzyme specific for the CCCGGG site. The restriction enzyme can be Smal. The primer pairs are selected from pair 1 (SEQ ID Nos 1 and 2) or from pair 2 (SEQ ID Nos 3 and
4).
[00012] Other objects, features and advantage of the present invention will become apparent to one of skill in the art after review of the specification and claims.
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS [00013] Not applicable.
DETAILED DESCRIPTION OF THE INVENTION [00014] It is disclosed here that genetic differences in the allele for the beta2-adrenoceptor
(ADR2) gene are associated with the milking characteristics of milking cows. This makes possible the use of genetic tools and analysis in breeding of cows to start to predict with accuracy the milking characteristics of daughters of specific bulls bred to specific maternal cows. [00015] We began the work described here by proposing that DNA sequence polymorphisms in and around bovine beta2-adrenoceptor (ADRB2) may cause or be associated with genes that cause the observed associations. First, we subcloned and sequenced bovine ADRB2, extending the region of known sequence beyond what was previously publicly available. Sequence obtained through this work, not previously in the public domain, includes 876 additional bases upstream from that described above. These bases are a total of 1099 that are 5' to the ATG start codon. An additional 695 bases downstream from the previously reported bases also were sequenced. These bases include a total of 1245 bases 3' to the TAA stop codon.
[00016] With this information in hand, we were then able to design oligonucleotide primers to be used to amplify and perform locus-specific re-sequencing of genomic DNA spanning regions of the bovine ADRB2 gene. These primers were used to amplify genomic DNA from 24 Holstein and 12 Brown Swiss dairy cows. After comparative genomic sequence was obtained, we analyzed the sequence using polyPhred software (Washington University, St. Louis, MO) and identified, among others, a Single Nucleotide Polymorphism (SNP) sequence at position 11, inclusive of the start ATG (hereafter referred to as "Al 1C"). The published sequence indicates the presence of a cytosine (C) nucleotide. We discovered a variant allele with an adenine (A) nucleotide at that position. Substitution of A for C at the nucleotide position 11 altered the amino acid sequence of ADRB2 protein by replacing a proline with a histidine at amino acid position 4 of the protein.
[00017] Subsequently we designed and validated a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay able to detect the presence of A and/or C nucleotide(s) at the Al 1C locus. This assay is based on the presence or absence of the smal restriction enzyme recognition site (CCCGGG) in DNA fragments which have been amplified by one of two primer pairs. The A allele at the Al 1C locus changes this sequence to CACGGG, which is not recognized, therefore is not digested by smal and consequently is identified as a heavier nucleotide in the PCR-RFLP test.
[00018] This polymorphism was found to be associated with milking characteristics. In particular, the A allele at the A11C locus is associated with higher somatic cell score (SMS) and therefore with a faster milking speed. This makes is possible to breed dairy cattle to increase the proportion of the herds having the A allele at the Al 1C locus, to improve the overall milking speed of the herd. The A allele is effective in both the heterozygous and homozygous conditions to improve the performance of the animal. [00019] "Polymorphism" refers generally to the ability of an organism or gene to occur in two or more different forms. In particular for purposes of the present invention, "polymorphism" refers to two or more different forms of the same gene. [00020] "Single Nucleotide Polymorphism" or "SNP" refers to a polymorphism that results from a difference in a single nucleotide.
[00021] A "Restriction Enzyme" refers to an endonuclease which bins to double stranded
DNA at a specific nucleotide sequence and then, if both strands of the DNA lack the appropriate modification at that sequence (including but not limited to methylation), cleaves the DNA either at the recognition sequence or at another site in the DNA molecule. Restriction enzymes are denoted by three-letter abbreviations followed by a strain designation and/or a Roman numeral distinguishing different enzymes from the same species or strain. Recognition sequences are written 5' to 3' for one strand only. Examples of restriction enzymes include Smal, BamHi, Bell, EcoRL Hindlll, and Xbal.
[00022] The term "Allele" refers generally to any of one or more alternative forms of a given gene or DNA segment; both or all alleles of a given gene are concerned with the same trait or characteristic, but the product or function coded for by a particular allele differs qualitatively and/or quantitatively from that coded for by other alleles of that gene. In a diploid cell or organism the members of an allelic pair (i.e., the two alleles of a given gene) occupy corresponding positions (loci) on a pair of homologous chromosomes; if these alleles are genetically identical the cell or organism is said to be homozygous. If the alleles are genetically different, the cell or organism is said to be heterozygous with respect to the particular gene. [00023] The polynucleotides of the present invention may be prepared by two general methods: (1) They may be synthesized from appropriate nucleotide triphosphates, or (2) they may be isolated from biological sources. Both methods utilize protocols well known in the art. The availability of nucleotide sequence information enables preparation of an isolated nucleic acid molecule of the invention by oligonucleotide synthesis. Synthetic oligonucleotides may be prepared by the phosphoramidite method employed in the Applied Biosystems 37A DNA Synthesizer or similar devices. The resultant construct may be purified according to methods known in the art, such as high performance liquid chromatography (HPLC). Complementary segments thus produced may be annealed such that each segment possesses appropriate cohesive termini for attachment of an adjacent segment. Adjacent segments maybe ligated by annealing cohesive termini in the presence of DNA ligase to construct an entire long double-stranded molecule. A synthetic DNA molecule so constructed may then be cloned and amplified in an appropriate vector.
[00024] The invention will be better understood upon consideration of the following non- limiting Examples. Unless otherwise specified, general cloning procedures, such as those set forth in Sambrook et al., MOLECULAR CLONING, Cold Spring Harbor Laboratory (1989) or Ausubel et al. CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley & Sons (2001), are used.
Example 1. Assessment of mRNA levels in leukocytes of cows with fast vs. slow-milking rates. [00025] Eight animals were selected by the duration of their milking and grouped as either slow or fast. For initial determinations, slow-milking animals were numbered 90, 264, 279 and 321. Fast-milking animals were numbered 272, 273, 281 and 289. Their blood (about 15 mL) was collected in EDTA-filled Vacutainers (BD, Franklin Lakes, NJ). Known sequences from NCBI along with the program "Oligo" were used to design primer sets specific for GAPDH, alpha2-, beta 1-, beta2-adrenoreceptors, and beta-arrestin. [00026] From the blood samples, RNA was isolated using the RNeasy RNA isolation protocol (Qiagen, Valencia, CA). One volume of whole blood was mixed with 5 volumes of erythrocyte lysis buffer. The mixture was incubated on ice, and during the incubation mixed by vortexing briefly twice. The mixture was next centrifuged at 400 g for 10 min at 4°C. The supernatant was discarded and the leukocyte pellet saved. The leukocyte pellet was added to more Buffer EL and vortexed to resuspend the leukocytes. The mixture was again centrifuged, after which the supernatant was discarded. The leukocyte pellet was loosened by flicking the tube. Buffer RLT (Qiagen)(with 10 μl jS-mercaptoethanol added per 1 ml buffer) was added to the leukocytes; for a starting blood volume of 4.0 ml or less, 2.0 ml was added; and for a greater blood volume, 4.0 ml was added. Next the mixture was homogenized until the sample was homogeneous. An equal volume of 70% alcohol was added to the homogenized lysate and vigorously shaken. Finally, the sample, including any precipitate that may have formed, was applied to an RNeasy midi spin column placed in a 15-ml centrifuge tube and centrifuged for 3000 to 5000 g for 5 min. For samples in excess of 4.0 ml, the extra sample was applied successively to the same column and the flow-through discarded. After the flow-through had been discarded, 4.0 ml of Buffer RW1 was added to the RNeasy column and centrifuged at 3000-5000 for 5 min to wash the column. The flow-through was discarded. Next 2.5 ml of Buffer RPE (diluted with 4 volumes of ethanol (96-100%) was added to the column which was again centrifuged at 3000-5000 for 2 min. Another 2.5 ml Buffer RPE was added to the column which was centrifuged at 3000-5000 for 5 min to dry the spin-column membrane. RNA was eluted from the column adding 150 μl or 250 μl RNase-free water to the column, which was left to stand for 1 min and then centrifuged at 3000-5000 g for 3 min. A second volume of RNase- free water was added to the column and spun down. The RNA was then salt-precipitated according to the manufacturer's protocol.
[00027] Next RNA was treated with DNA-free DNase to remove trace levels of DNA, according to the manufacturer's protocol (Ambion, Austin, TX). To the RNA sample purified as described above, were added 0.1 volume of 10X DNase I Buffer and 1 μl of DNase I (2 units) to the RNA, which solution was mixed gently and incubated at 37°C for 20-30 min. Ambion DNase Inactivation reagent was resuspended by flicking or vortexing. From that tube, the greater of 0.1 volume or 5 μl was added to the sample and mixed well. The tube was incubated for 2 min at room temperature. The tube was next centrifuged at 10,000 g for about 1 min to pellet the DNase inactivation reagent.
[00028] Spectrophotometry was then used to determine RNA concentration, and 1 μg
RNA was loaded on a 1% agarose gel using ethidium bromide to ensure quality. [00029] Following the manufacturer's protocol, cDNA templates were made from the
RNA using Omniscript (Qiagen) for Real Time PCR analysis. The Omniscript 10X Buffer RT, dNTP mix and RNase-free water were first thawed and mixed by vortexing. Qiagen RNase inhibitor was diluted to a final concentration of 10 units/μl in lx Buffer RT and mixed by vortexing briefly. Master mix (2.0 μl of lOx Buffer RT, 2.0 μl dNTP mix, 2.0 μl oligo dT primer (10 uM), 0.5 μl Rnase inhibitor (10 units/μl), 1.0 μl Omniscript reverse transcriptase and double distilled water) was prepared on ice. Master solution was distributed to the various tubes, and template RNA (0.6 to 0.68 μl/tube) was added and mixed. The resulting solutions were incubated at 37°C for 60 min.
[00030] All samples were run by LightCycler (Idaho Technology, Inc., Salt Lake City,
UT) protocol using the SYBR-green kit from Roche Molecular Biochemicals, except for beta2- adrenoreceptor, for which the SYBR-green kit (Qiagen) was used. Samples were run in duplicate, and all were normalized using GAPDH. Cycle thresholds (determined by the second derivative growth curve) of samples were then compared between the groups of slow and fast milkers. To determine if there were any significant differences between slow and fast milkers, the SAS statistical package was used to perform a Pearson correlation coefficient. The results suggested that duration of milking and rate of milk removal are associated with the amount of beta2-adrenoreceptor mRNA levels in blood, and it was decided to more thoroughly characterize the beta2-adrenoreceptor gene in cattle.
[00031] It was discovered that there was a polymorphism of the beta2-adrenoreceptor at the 11th nucleotide (A replaced C in some instances, resulting in a substitution of histidine for proline at the fourth amino acid).
Example 2. Associations Between Al 1C Genotype and SCS and/or Milking Speed in Dairy Cows
[00032] Bovine DNAs are available from the Cooperative Dairy DNA Repository
(CDDR) population (Gene Evaluation and Mapping Laboratory, Bldg. 200 Rm 2A, ARS- USDA, BARC-East Beltsville, MD 20705). SCS phenotypes have been obtained for all CDDR animals. For a subset of the CDDR animals, there also are data on the milking speed (MS). First, CDDR animals with MS data were genotyped, along with a subset of the remainder of the CDDR animals representing "high" and "low" Somatic Cell Score (SCS) phenotypic classes, with the AllC assay. DNA samples were obtained and assayed. Data sets were distributed and analyzed in duplicate. The analysis revealed a correlation between Al 1C and SCS. [00033] Six hundred sixty three animals from the CDDR were genotyped for the Al lC locus using the either of the following pairs of primers: TGGAACTGGCTGAACTGACA (SEQ ID NO 1) AGTTGATGGCTTCCTTGTGG (SEQ ID NO 2) AGGTCCGCTCGCTGAGG (SEQ ID NO 3) GTTCCAGCGTGACGTTTTG (SEQ ID NO 4 ) [00034] Table 1 shows a disproportionate distribution of Al 1C genotypes into "High" and
"Low" SCS phenotypic categories.
Table 1. AllC Genotypes and SCS distribution of 663 CDDR bulls. AA AC CC Total
High # 9 88 248 345
Low # 5 55 258 318
Total 14 143 506 663
Prop . High 0.643 0.615 0.490 0.520
Prop . Low 0.357 0.385 0.510 0.480 [00035] In addition, Table 2 contains average estimated transmitting abilities (ETA) for
SCS and frequencies by Al IC genotype. Results from statistical analyses of the data indicate that genotypes AA, AC and CC are significantly different from the mean SCS (p<0.025) and that genotypes AA and AC are significantly higher than the mean SCS (p<0.01). Furthermore, animals with the CC genotype have significantly different (i.e., lower) SCS phenotypes than animals with AA and AC genotypes (p<0.05).
Table 2. Average SCS ETA and frequency by Al IC genotype among 663 CDDR bulls. A AC CC Total
SCS ETA 314.5 312.8 307.0 0.520 Genotype Freq. 0.021 0.216 0.763
[00036] Table 3 shows the distribution of milking speed (MS) classifications according to genotype, and Table 4 illustrates the average ETA for MS by genotype. Because of the small number of AA animals, there is not a significant association between MS and Al lC genotype at the 5% level. However, the trend in Table 3 clearly shows that the CC genotype has a lower proportion of bulls transmitting fast MS.
Table 3. Al IC Genotypes and Milking Speed distribution of 663 CDDR bulls. AA AC CC Total
Fast # 13 46 108 167
Slow # 7 36 120 163
Total 20 82 228 330
Pro . Fast 0.650 0.561 0.474 0.506
Pro . Slow 0.350 0.439 0.526 0.494
[00037] In Table 4, the AA genotype tends to have a higher average ETA for MS.
Table 4. Average ETA for milking speed and frequency by Al IC genotype among 663 CDDR bulls. AA AC CC
MS ETA 70 68.81707 64.02609
Genotype Freq. 0.061 0.248 0.691
[00038] From these tables it appears that the AA and AC genotypes (that are significantly associated SCS) are also associated with higher milking speed. This is in agreement with studies (McClelland, "A comparison of objective and subject measures of milking speed on Canadian Holstein-Friesians", University of Guelph, 1983, and Boettcher et al., "Development of an udder health index for sire selection based on somatic cell score, udder conformation, and milking speed", J Dairy Sci 81(4):1157-1168, 1998) that have shown that higher milking speed is genetically correlated with higher SCS and mastitis incidence. Since the bulls that had MS ETAs represented only a subset (330) of the total group (663), it is likely that with a larger sample size, significant association could be shown between MS and the Al IC locus.
[00039] This discovery enables for the first time the testing and selection of animals for breeding and/or alternative management practices based on the results of the inventive assay.
The assay results correlate with the SCS and enable the choice of animals with improved MS and mastitis resistance. In addition to using these discoveries to select animals for phenotypes related to SCS, these discoveries can also be used to select animals in an attempt to effect population changes in MS and mastitis resistance. Applying the assay will enable the selection of animals with SCS which will ultimately improve the herd averages for MS and mastitis resistance.
[00040] This invention also includes a kit containing reagents that can be used to identify allelic composition at the loci described herein.
[00041] The present invention is not limited to the embodiments described and exemplified above, but is capable of variation and modification within the scope of the appended claims.

Claims

CLA OR CLAIMS What is claimed is:
1. A method for breeding cows for desired milking characteristics comprising the steps of: a. identifying the allele of the bovine beta2-adrenergic receptor gene in at least one potential parent animals; and b. breeding male and female animals to create a daughter having at least one allele of the beta2-adregenic receptor gene associated with improved milking characteristics.
2. The method of claim 1 wherein the method for identifying the allele includes isolating DNA from the parent and screening with a method selected from the group consisting of direct sequencing, primer extension, restriction length fragment polymorphism, and allele- specific hybridization.
3. The method of claim 1 whereby the screening method is intended to identify AllC alleles.
4. A method of identifying a bull whose daughter cows will have a faster milking time, the method comprising the steps of a. obtaining a sample of DNA from a bull; b. combining the DNA with a pair of PCR probes comprising SEQ IDs 1 and 2 or SEQ IDS 3 and 4; c. incubating the DNA under conditions permitting the DNA bounded by the PCR probes to produce DNA amplicons; d. isolating the DNA amplicons; e. combining the DNA amplicons with a restriction enzyme specific for CCCGGG for a sufficient time to produce a mixture of DNA fragments from the amplicons comprising CCCGGG; f. applying the DNA fragment mixture to a gel and permitting migration of the mixture components for a time sufficient for them to separate; and g. observing the sizes of DNA on the gel, with the largest fragments being correlated with the A genotype and with better SCS phenotype, and the smaller fragments being associated with the C genotype and less desirable SCS phenotype.
5. A milking attribute PCR-RFLP kit, which comprises: a pair of primers which flank the 11th nucleotide position of the bovine beta2- adrenoreceptor gene, and a restriction enzyme specific for the CCCGGG site.
6. The kit of claim 5 wherein the restriction enzyme is Smal.
7. The kit of claim 5 wherein the primer pairs are selected from pair 1 (SEQ ID Nos 1 and 2) or from pair 2 (SEQ ID Nos 3 and 4).
EP04784592A 2003-09-23 2004-09-21 Adrenergic receptor snp for improved milking characteristics Withdrawn EP1673382A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50511303P 2003-09-23 2003-09-23
PCT/US2004/030774 WO2005030789A1 (en) 2003-09-23 2004-09-21 Adrenergic receptor snp for improved milking characteristics

Publications (2)

Publication Number Publication Date
EP1673382A1 true EP1673382A1 (en) 2006-06-28
EP1673382A4 EP1673382A4 (en) 2006-10-18

Family

ID=34392977

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04784592A Withdrawn EP1673382A4 (en) 2003-09-23 2004-09-21 Adrenergic receptor snp for improved milking characteristics

Country Status (7)

Country Link
EP (1) EP1673382A4 (en)
CN (1) CN100422202C (en)
AU (1) AU2004276248A1 (en)
BR (1) BRPI0414583A (en)
CA (1) CA2539551A1 (en)
RU (1) RU2006113558A (en)
WO (1) WO2005030789A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008140467A2 (en) * 2006-09-29 2008-11-20 Pfizer Inc. Genetic markers and methods for improving dairy productivity and fitness traits
CN101693923B (en) * 2009-11-09 2012-02-22 山东奥克斯生物技术有限公司 HSP70A1A gene SNP loci, application and kit for selecting heat-resistant cows
CN110106250B (en) * 2019-05-28 2020-11-27 中国农业大学 Molecular marker related to resistance of metabolic diseases of dairy cows in perinatal period and application of molecular marker

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010714A1 (en) * 1989-03-15 1990-09-20 Wisconsin Alumni Research Foundation Genetic marker for superior milk production in dairy cattle
WO1999019512A1 (en) * 1997-10-10 1999-04-22 University Of Cincinnati β-ADRENERGIC RECEPTOR POLYMORPHISMS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593092B2 (en) * 2000-04-04 2003-07-15 Abbott Laboratories Beta 2 adrenergic polymorphism detection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010714A1 (en) * 1989-03-15 1990-09-20 Wisconsin Alumni Research Foundation Genetic marker for superior milk production in dairy cattle
WO1999019512A1 (en) * 1997-10-10 1999-04-22 University Of Cincinnati β-ADRENERGIC RECEPTOR POLYMORPHISMS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2005030789A1 *

Also Published As

Publication number Publication date
BRPI0414583A (en) 2006-11-07
CN100422202C (en) 2008-10-01
RU2006113558A (en) 2007-11-10
EP1673382A4 (en) 2006-10-18
AU2004276248A1 (en) 2005-04-07
CA2539551A1 (en) 2005-04-07
CN1852916A (en) 2006-10-25
WO2005030789A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
US20070186298A1 (en) Follistatin gene as a genetic marker for reproductive and performance traits in pigs
JP2011501659A (en) Horned and ahornless bovine genetic markers and related methods
CN101970688A (en) Methods of using genetic markers and related epistatic interactions
MXPA06009452A (en) Leptin promoter polymorphisms and uses thereof.
AU2009275988B2 (en) A genetic marker test for Brachyspina and fertility in cattle
JP2015526099A (en) Genetic markers for mastitis resistance
US10626459B2 (en) Methods and kits for the identification of animals having a greater potential for desirable characteristics, and for the early identification of fat deposits in bovines
MX2007008623A (en) Dna markers for cattle growth.
WO2011028134A9 (en) Biological markers and uses therefor
Mišeikienė et al. The influence of TLR4 gene polymorphisms on milk quality and composition of Lithuanian Holstein cows
KR101796158B1 (en) SNP markers of NAT9 gene for prediction of pigs litter size and methods for selection of fecund pigs using the same
CA2600677A1 (en) Association between markers in the leptin gene and carcass traits in commercial feedlot steer and heifers
US8003328B2 (en) Bovine polymorphisms and methods of predicting bovine traits
Wu et al. Restriction fragment length polymorphism in the exon 2 of the BoLA-DRB3 gene in Chinese Holstein of the south China
US20100009374A1 (en) Sire early selection for male fertility using single nucleotide polymorphisms (snps) of the dazl gene
WO2005030789A1 (en) Adrenergic receptor snp for improved milking characteristics
KR101289484B1 (en) Method of genetic test for diagnosis of marbling trait in Korean cattle
US20070209084A1 (en) Adrenergic Receptor SNP for Improved Milking Characteristics
KR101307008B1 (en) Diagnosis method of high meat producing Hanwoo using the DNA marker associated with marbling score
KR20110038490A (en) Development of dna marker associated with higher meat quantity and diagnosis method of high meat quantity producing hanwoo using the dna marker
Mišeikienė et al. Utjecaj polimorfizma gena TLR4 na kvalitetu i sastav mlijeka krava holstein pasmine u Litvi
MXPA06003211A (en) Adrenergic receptor snp for improved milking characteristics
KR101796160B1 (en) SNP markers of DACT3 gene for prediction of pigs litter size and methods for selection of fecund pigs using the same
KR101280652B1 (en) Technology of genome selection related to backfat thickness in Korean cattle
EP2149611A1 (en) A genetic marker test for brachyspina and fertility in cattle

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060419

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20060914

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080103

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090129